Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 324

1.

Elevated levels of the long pentraxin 3 in paracetamol-induced human acute liver injury.

Craig DG, Lee P, Pryde EA, Walker SW, Beckett GJ, Hayes PC, Simpson KJ.

Eur J Gastroenterol Hepatol. 2013 Mar;25(3):359-67. doi: 10.1097/MEG.0b013e32835ac77a.

PMID:
23169308
2.

Persistently elevated troponin I in paracetamol hepatotoxicity: association with liver injury, organ failure, and outcome.

Moore JK, Craig DG, Pryde EA, Walker SW, Beckett GJ, Hayes PC, Simpson KJ.

Clin Toxicol (Phila). 2013 Aug;51(7):532-9. doi: 10.3109/15563650.2013.816853. Epub 2013 Jul 5.

PMID:
23829708
3.

Serum neopterin and soluble CD163 as markers of macrophage activation in paracetamol (acetaminophen)-induced human acute liver injury.

Craig DG, Lee P, Pryde EA, Hayes PC, Simpson KJ.

Aliment Pharmacol Ther. 2013 Dec;38(11-12):1395-404. doi: 10.1111/apt.12530. Epub 2013 Oct 20.

4.

An elevated neutrophil-lymphocyte ratio is associated with adverse outcomes following single time-point paracetamol (acetaminophen) overdose: a time-course analysis.

Craig DG, Kitto L, Zafar S, Reid TW, Martin KG, Davidson JS, Hayes PC, Simpson KJ.

Eur J Gastroenterol Hepatol. 2014 Sep;26(9):1022-9. doi: 10.1097/MEG.0000000000000157.

PMID:
25045842
5.

Comparison of the sequential organ failure assessment score with the King's College Hospital criteria and the model for end-stage liver disease score for the prognosis of acetaminophen-induced acute liver failure.

Cholongitas E, Theocharidou E, Vasianopoulou P, Betrosian A, Shaw S, Patch D, O'Beirne J, Agarwal B, Burroughs AK.

Liver Transpl. 2012 Apr;18(4):405-12. doi: 10.1002/lt.23370.

6.

Circulating apoptotic and necrotic cell death markers in patients with acute liver injury.

Craig DG, Lee P, Pryde EA, Masterton GS, Hayes PC, Simpson KJ.

Liver Int. 2011 Sep;31(8):1127-36. doi: 10.1111/j.1478-3231.2011.02528.x. Epub 2011 Apr 6.

PMID:
21745283
7.

Subtotal hepatectomy and whole graft auxiliary transplantation for acetaminophen-associated acute liver failure.

Rajput I, Prasad KR, Bellamy MC, Davies M, Attia MS, Lodge JP.

HPB (Oxford). 2014 Mar;16(3):220-8. doi: 10.1111/hpb.12124. Epub 2013 Jul 22.

8.

Patients with acute liver failure listed for superurgent liver transplantation in France: reevaluation of the Clichy-Villejuif criteria.

Ichai P, Legeai C, Francoz C, Boudjema K, Boillot O, Ducerf C, Mathurin P, Pruvot FR, Suc B, Wolf P, Soubrane O, Le Treut YP, Cherqui D, Hannoun L, Pageaux GP, Gugenheim J, Letoublon C, Saric J, Di Martino V, Abergel A, Chiche L, Antonini TM, Jacquelinet C, Castaing D, Samuel D; French Liver Transplant Teams.

Liver Transpl. 2015 Apr;21(4):512-23. doi: 10.1002/lt.24092.

9.

Elevated levels of systemic pentraxin 3 are associated with thin-cap fibroatheroma in coronary culprit lesions: assessment by optical coherence tomography and intravascular ultrasound.

Koga S, Ikeda S, Yoshida T, Nakata T, Takeno M, Masuda N, Koide Y, Kawano H, Maemura K.

JACC Cardiovasc Interv. 2013 Sep;6(9):945-54. doi: 10.1016/j.jcin.2013.04.024. Epub 2013 Aug 14.

10.

Patients with the worst outcomes after paracetamol (acetaminophen)-induced liver failure have an early monocytopenia.

Moore JK, MacKinnon AC, Man TY, Manning JR, Forbes SJ, Simpson KJ.

Aliment Pharmacol Ther. 2017 Feb;45(3):443-454. doi: 10.1111/apt.13878. Epub 2016 Nov 28.

PMID:
27896824
11.

Medical and psychiatric outcomes for patients transplanted for acetaminophen-induced acute liver failure: a case-control study.

Karvellas CJ, Safinia N, Auzinger G, Heaton N, Muiesan P, O'Grady J, Wendon J, Bernal W.

Liver Int. 2010 Jul;30(6):826-33. doi: 10.1111/j.1478-3231.2010.02243.x. Epub 2010 Apr 8.

PMID:
20408947
12.

Pentraxin-3 serum levels are associated with disease severity and mortality in patients with systemic inflammatory response syndrome.

Bastrup-Birk S, Skjoedt MO, Munthe-Fog L, Strom JJ, Ma YJ, Garred P.

PLoS One. 2013 Sep 9;8(9):e73119. doi: 10.1371/journal.pone.0073119. eCollection 2013.

13.

Overdose pattern and outcome in paracetamol-induced acute severe hepatotoxicity.

Craig DG, Bates CM, Davidson JS, Martin KG, Hayes PC, Simpson KJ.

Br J Clin Pharmacol. 2011 Feb;71(2):273-82. doi: 10.1111/j.1365-2125.2010.03819.x.

14.

Could pentraxin 3 be a new diagnostic marker for excessive inflammatory response in cardiac surgery?

Holubcova Z, Kunes P, Mandak J, Kolackova M, Andrys C, Krejsek J, Holubec T.

Thorac Cardiovasc Surg. 2014 Dec;62(8):670-6. doi: 10.1055/s-0034-1384668. Epub 2014 Aug 22.

PMID:
25148605
15.

Pentraxin 3 and C-reactive protein in severe meningococcal disease.

Sprong T, Peri G, Neeleman C, Mantovani A, Signorini S, van der Meer JW, van Deuren M.

Shock. 2009 Jan;31(1):28-32. doi: 10.1097/SHK.0b013e31817fd543.

PMID:
18650775
16.

Emergency subtotal hepatectomy: a new concept for acetaminophen-induced acute liver failure: temporary hepatic support by auxiliary orthotopic liver transplantation enables long-term success.

Lodge JP, Dasgupta D, Prasad KR, Attia M, Toogood GJ, Davies M, Millson C, Breslin N, Wyatt J, Robinson PJ, Bellamy MC, Snook N, Pollard SG.

Ann Surg. 2008 Feb;247(2):238-49. doi: 10.1097/SLA.0b013e31816401ec.

PMID:
18216528
17.

Relationships between plasma pentraxin 3 levels and inflammation markers patients with tunneled permanent catheter in hemodialysis.

Yigit IP, Dogukan A, Taskapan H, Comert M, Ilhan N, Ulu R, Aygen B.

J Vasc Access. 2015 Sep-Oct;16(5):377-81. doi: 10.5301/jva.5000409. Epub 2015 Jun 12.

PMID:
26070095
18.

Pentraxin-3 as a local inflammatory marker in chronic spontaneous urticaria.

Kasperska-Zajac A, Grzanka A, Misiolek M, Mazur B, Machura E.

Cytokine. 2015 Dec;76(2):566-568. doi: 10.1016/j.cyto.2015.04.016. Epub 2015 May 14.

PMID:
25982553
19.

The yin-yang of long pentraxin PTX3 in inflammation and immunity.

Daigo K, Mantovani A, Bottazzi B.

Immunol Lett. 2014 Sep;161(1):38-43. doi: 10.1016/j.imlet.2014.04.012. Epub 2014 May 1. Review.

PMID:
24792672
20.

Cardiac rehabilitation decreases plasma pentraxin 3 in patients with cardiovascular diseases.

Fukuda T, Kurano M, Iida H, Takano H, Tanaka T, Yamamoto Y, Ikeda K, Nagasaki M, Monzen K, Uno K, Kato M, Shiga T, Maemura K, Masuda N, Yamashita H, Hirata Y, Nagai R, Nakajima T.

Eur J Prev Cardiol. 2012 Dec;19(6):1393-400. doi: 10.1177/1741826711422990. Epub 2011 Sep 13.

PMID:
21914683

Supplemental Content

Support Center